Company: & Vice President, SfPM
Job title: Principal Investigator, Fred Hutchinson Cancer Center, Co-Founder, SEngine Precision Medicine
Christopher Kemp, PhD has studied the genetic and molecular basis of cancer for over 30 years and is internationally recognized for his pioneering research on tumor suppressor genes. Dr. Kemp received in BS in Biology from Case Western Reserve University, an MS in Toxicology from Oregon State University, and a PhD in Oncology from the University of Wisconsin, Madison. This was followed by five years of postdoctoral research training at the Beatson Institute for Cancer Research. Dr. Kemp is a Full Member in the Division of Human Biology at the Fred Hutchinson Cancer Research Center where he has been since 1994. He is a co-founder of Cure First, SEngine Precision Medicine, and the Society of Functional Precision Medicine whose collective mission is to identify and develop safer, more effective targeted cancer therapies.